Verbessert die Überwachung von Patienten mit Barrett-Ösophagus das Überleben?

Corley DA, Levin TR, Habel LA, Weiss NS, Buffler PA. Surveillance and Survival in Barrett’s adenocarcinomas: a population based study. Gastroenterology 2002; 122: 633-640

Literatur

• 1 Lagergren J, Bergstrom R, Lindgren A. et al . Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.  N Engl J Med. 1999;  340 825-831
• 2 Cameron A, Lomboy C. Barrett’s esophagus: age, prevalence, and extent of columnar epithelium.  Gastroenterology. 1992;  103 1241-1245
• 3 Bonelli L. Barrett’s esophagus: results of a multicenter survey.  Endoscopy. 1993;  25 (suppl) 652-654
• 4 Robinson M, Earnest D, Rodriguez-Stanley S. et al . Heartburn requiring frequent antacid use may indicate significant illness.  Arch Intern Med. 1998;  158 2373-2376
• 5 Gerson L, Shetler K, Triadafilopoulos G. Prevalence of Barrett’s esophagus in asymptomatic individuals.  Gastroenterology. 2002;  123 461-467
• 6 Shaheen N, Crosby M, Bozymski E. et al . Is there a publication bias in the reporting of cancer risk in Barrett’s esophagus?.  Gastroenterology. 2000;  119 333-338
• 7 Blot W, McLaughlin J. The changing epidemiology of esophageal cancer.  Semin Oncol. 1999;  26 (suppl 15) 2-8
• 8 Sabik J, Rice T, Goldblum J. et al . Superficial esophageal carcinoma.  Ann Thorac Surg. 1995;  60 896-902
• 9 Sampliner R. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett’s esophagus. The Practice Parameters Committee of the American College of Gastroenterology.  Am J Gastroenterol. 2002;  97 1888-1895
• 10 Sonnenberg A, Soni A, Sampliner R. Medical decision analysis of endoscopic surveillance of Barrett’s oesophagus to prevent oesophageal adenocarcinoma.  Aliment Pharmacol Ther. 2002;  16 41-50
• 11 Wright T, Gray M, Morris A. et al . Cost effectiveness of detecting Barrett’s cancer.  Gut. 1996;  39 574-579
• 12 Van Sandick J, Lanschot J v, Kuiken B. et al . Impact of endoscopic biopsy surveillance of Barrett’s oesophagus on pathological stage and clinical outcome of Barrett’s carcinoma.  Gut. 1998;  43 216-222
• 13 Bani-Hani K, Sue-Ling H, Johnston D. et al . Barrett’s oesophagus: results from a 13-year surveillance programme.  Eur J Gastroenterol Hepatol. 2000;  12 649-654
• 14 Thomas P, Doddoli C, Lienne P. et al . Changing patterns and surgical results in adenocarcinoma of the oesophagus.  Br J Surg. 1997;  84 119-125
• 15 Sackett D. Bias in analytic research.  J Chronic Dis. 1979;  32 51-63
• 16 Dulai G. Surveying the case for surveillance.  Gastroenterology. 2002;  122 820-825
• 17 Dulai G, Guha S, Kahn K. et al . Preoperative prevalence of Barrett’s esophagus in esophageal adenocarcinoma: a systematic review.  Gastroenterology. 2002;  122 26-33
• 18 Provenzale D, Schmitt C, Wong J. Barrett’s esophagus: A new look at surveillance based on emerging estimates of cancer risk.  Am J Gastroenterol. 1999;  94 2043-2053
• 19 Endlicher E, Ruemmele P, Beer S. et al . Endoscopic and histologic diagnosis of Long- and Short-Barrett’s esophagus.  Gastrointest Endosc. 2002;  55 AB203
• 20 Cameron A, Kamath P, Carpenter H. Barrett’s esophagus: The prevalence of short and long segments of specialized intestinal metaplasia in the distal esophagus on routine endoscopy.  Gastroenterology. 1995;  91 A65
• 21 Ott R, Roesch TJM, Birkner B. et al . Much ado about the „ultrashort” Barrett esophagus? Results from the munich multicenter study.  Gastroenterology. 1999;  116 A275
• 22 Weston A, Krmpotich P, Makdisi W. et al . Short segment Barrett’s esophagus: Clinical and histological features, associated endoscopic findings, and association with gastric intestinal metaplasia.  Am J Gastroenterol. 1996;  91 981-986
• 23 Winters C J, Spurling T, Chobanian S. et al . Barrett’s esophagus: a prevalent occult complication of gastroesophageal reflux disease.  Gastroenterology. 1987;  92 118-124
• 24 Eloubeidi M, Provenzale D. Does this patient have Barrett’s esophagus? The Utility of predicting Barrett’s esophagus at the index endoscopy.  Am J Gastroenterol. 1999;  94 937-943
• 25 Seitz G, Vieth M, Stolte M. Does endoscopically negative Barrett’s mucosa really exist?.  Gastrointest Endosc. 2002;  55 AB203
• 26 Weinstein W, Leh W, Lewin K. et al . How often is short segement Barrett’s esophagus proven histologically? A prospective study.  Gastroenterology. 2002;  122 (suppl) A293
• 27 Voutilainen M, Färkkilä M, Juhola M. et al . Specialized columnar epithelium of the esophagogastric junction: prevalence and associations.  Am J Gastroenterol. 1999;  94 913-918
• 28 Nandurkar S, Talley N, Martin C. et al . Short segment Barrett’s oesophagus: prevalence, diagnosis and associations.  Gut. 1997;  40 710-715
• 29 Canto M, Setrakian S, Willis J. et al . Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett’s esophagus.  Gastrointest Endosc. 2000;  51 560-568